Facebook has unveiled Oculus Rift S, a new version of its PC headset Oculus Rift, at the ongoing Game Developers Conference (GDC) here.
Oculus Rift S will be launched this spring for $399, Facebook said.
Rift S replaces the original Rift with an upgrade to a higher resolution display, improved optics and a feature called Passthrough+, which gives users a glimpse of the real world around them without ever taking off the headset.
Built on the Rift Platform, the new VR headset combines the built-in Oculus Insight tracking technology with the power of your PC.
“We partnered with Lenovo to design Rift S, drawing on their experience in the VR and AR space and feedback from the Lenovo Legion gaming community,” the Oculus team wrote in a blog post on Wednesday.
Fake ads on Facebook are spreading rumours about the ill-effect of anti-HIV drugs, targeting LGBTQ Facebook and Instagram users and are causing significant harm to public health, a non-profit organization GLAAD has written in a letter to CEO Mark Zuckerberg.
“We are urgently reaching out to Facebook and Instagram regarding factually inaccurate advertisements which suggest negative health effects of Truvada PrEP (Pre-Exposure Prophylaxis).
“We request that Facebook and Instagram remove the advertisements and also publicly address the misinformation that the platforms allowed to spread,” the non-profit organization said in the letter.
Using Facebook’s and Instagram’s targeted advertising programs, various law firms are attempting to recruit gay and bisexual men who use Truvada PrEP as an HIV preventative to join a lawsuit, claiming that the drug has caused harmful side effects in this patient population, specifically bone density and kidney issues.
“This is despite numerous studies underscoring the safety of TDF in HIV-negative PrEP users,” said GLAAD.
Leading public health officials, medical professionals, and dedicated PrEP navigators and outreach coordinators have shared that these advertisements on Facebook and Instagram are being directly cited by at-risk community members expressing heightened fears about taking PrEP.
The US Centers for Disease Control and Prevention reports that when taken daily, PrEP is highly effective for preventing HIV from sex or injection drug use.
“Studies have shown that PrEP reduces the risk of getting HIV from sex by about 99 per cent when taken daily.”
By allowing these advertisements to persist on their platforms, said the letter, Facebook and Instagram are convincing at-risk individuals to avoid PrEP, invariably leading to avoidable HIV infections.
“You are harming public health.”
Facebook was yet to comment on the letter.
Facebook’s Advertising Policy regarding misinformation in ads states that “Facebook prohibits ads that include claims debunked by third-party fact checkers or, in certain circumstances, claims debunked by organizations with particular expertise.”